![](https://webarchive.library.unt.edu/eot2008/20090118123705im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |
Prescription and Over-the-Counter Drug Product List
25th Edition
Cumulative Supplement Number 11: November 2006
NOTE: The format for the Monthly Additions/Deletions Drug
Product List has changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.5
CUMULATIVE SUPPLEMENT LEGEND.
AMANTADINE HYDROCHLORIDE
SYRUP; ORAL
AMANTADINE HYDROCHLORIDE
>A> AA + VINTAGE 50MG/5ML N77992 001 Dec 12, 2006 Nov NEWA
AMPHOTERICIN B
>D> LOTION; TOPICAL
>D> FUNGIZONE
>D> + APOTHECON 3% N60570 001 Nov DISC
>A> @ 3% N60570 001 Nov DISC
AMPICILLIN SODIUM; SULBACTAM SODIUM
INJECTABLE; INJECTION
AMPICILLIN AND SULBACTAM
>A> AP INSTITUTO EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL N65314 001 Nov 27, 2006 Nov NEWA
AMPICILLIN/AMPICILLIN TRIHYDRATE
CAPSULE; ORAL
PRINCIPEN
>D> AB APOTHECON EQ 250MG BASE N62888 001 Mar 04, 1988 Nov DISC
>A> @ EQ 250MG BASE N62888 001 Mar 04, 1988 Nov DISC
>D> AB + EQ 500MG BASE N62888 002 Mar 04, 1988 Nov DISC
>A> @ EQ 500MG BASE N62888 002 Mar 04, 1988 Nov DISC
>D> AB EQ 500MG BASE N61392 002 Nov CRLD
>A> AB + EQ 500MG BASE N61392 002 Nov CRLD
ANIDULAFUNGIN
INJECTABLE; IV (INFUSION)
ERAXIS
>A> + VICURON 100MG/VIAL N21632 002 Nov 14, 2006 Nov NEWA
CALCITRIOL
INJECTABLE; INJECTION
CALCITRIOL
>A> AP FRESENIUS MEDCL 0.001MG/ML N75766 001 Feb 20, 2003 Nov CAHN
>A> AP 0.002MG/ML N75766 002 Feb 20, 2003 Nov CAHN
>D> AP XANODYNE PHARM 0.001MG/ML N75766 001 Feb 20, 2003 Nov CAHN
>D> AP 0.002MG/ML N75766 002 Feb 20, 2003 Nov CAHN
CALCIUM ACETATE
CAPSULE; ORAL
PHOSLO
>A> @ FRESENIUS MEDCL EQ 84.5MG CALCIUM N21160 001 Apr 02, 2001 Nov CAHN
>A> @ EQ 169MG CALCIUM N21160 002 Apr 02, 2001 Nov CAHN
>D> @ NABI EQ 84.5MG CALCIUM N21160 001 Apr 02, 2001 Nov CAHN
>D> @ EQ 169MG CALCIUM N21160 002 Apr 02, 2001 Nov CAHN
PHOSLO GELCAPS
>A> + FRESENIUS MEDCL EQ 169MG CALCIUM N21160 003 Apr 02, 2001 Nov CAHN
>D> + NABI EQ 169MG CALCIUM N21160 003 Apr 02, 2001 Nov CAHN
TABLET; ORAL
PHOSLO
>A> @ FRESENIUS MEDCL EQ 169MG CALCIUM N19976 001 Dec 10, 1990 Nov CAHN
>D> @ NABI EQ 169MG CALCIUM N19976 001 Dec 10, 1990 Nov CAHN
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
SOLUTION; INTRAPERITONEAL
DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
>D> AT BAXTER HLTHCARE 18.3MG/100ML;2.5GM/100ML;5.08MG/100 N20183 002 Dec 04, 1992 Nov CTEC
>A> 18.3MG/100ML;2.5GM/100ML;5.08MG/100 N20183 002 Dec 04, 1992 Nov CTEC
DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER
>D> AT BAXTER HLTHCARE 18.3MG/100ML;3.5GM/100ML;5.08MG/100 N20183 003 Dec 04, 1992 Nov CTEC
>A> 18.3MG/100ML;3.5GM/100ML;5.08MG/100 N20183 003 Dec 04, 1992 Nov CTEC
DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
>D> AT BAXTER HLTHCARE 18.3MG/100ML;4.25GM/100ML;5.08MG/10 N20183 004 Dec 04, 1992 Nov CTEC
>A> 18.3MG/100ML;4.25GM/100ML;5.08MG/10 N20183 004 Dec 04, 1992 Nov CTEC
INPERSOL-LC/LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER
>D> AT FRESENIUS 18.4MG/100ML;3.5GM/100ML;5.08MG/100 N20374 003 Jun 13, 1994 Nov CTEC
>A> 18.4MG/100ML;3.5GM/100ML;5.08MG/100 N20374 003 Jun 13, 1994 Nov CTEC
CAPTOPRIL
TABLET; ORAL
CAPTOPRIL
>D> AB APOTHECON 12.5MG N74472 001 Mar 31, 1995 Nov DISC
>A> @ 12.5MG N74472 001 Mar 31, 1995 Nov DISC
>D> AB 25MG N74472 002 Mar 31, 1995 Nov DISC
>A> @ 25MG N74472 002 Mar 31, 1995 Nov DISC
>D> AB 50MG N74472 003 Mar 31, 1995 Nov DISC
>A> @ 50MG N74472 003 Mar 31, 1995 Nov DISC
>D> AB 100MG N74472 004 Mar 31, 1995 Nov DISC
>A> @ 100MG N74472 004 Mar 31, 1995 Nov DISC
CARVEDILOL
TABLET; ORAL
COREG
>D> GLAXOSMITHKLINE 3.125MG N20297 004 May 29, 1997 Nov CAHN
>D> 6.25MG N20297 003 Sep 14, 1995 Nov CAHN
>D> + 12.5MG N20297 002 Sep 14, 1995 Nov CAHN
>D> 25MG N20297 001 Sep 14, 1995 Nov CAHN
>A> SMITHKLINE BEECHAM 3.125MG N20297 004 May 29, 1997 Nov CAHN
>A> 6.25MG N20297 003 Sep 14, 1995 Nov CAHN
>A> + 12.5MG N20297 002 Sep 14, 1995 Nov CAHN
>A> 25MG N20297 001 Sep 14, 1995 Nov CAHN
CEFAZOLIN SODIUM
INJECTABLE; INJECTION
CEFAZOLIN
>D> AP ORCHID HLTHCARE EQ 1GM BASE N65244 001 Aug 12, 2005 Nov CPOT
>A> AP EQ 1GM BASE/VIAL N65244 001 Aug 12, 2005 Nov CPOT
>D> AP EQ 10GM BASE N65247 001 Aug 12, 2005 Nov CPOT
>A> AP EQ 10GM BASE/VIAL N65247 001 Aug 12, 2005 Nov CPOT
CEFAZOLIN SODIUM
>A> + SAMSON MEDCL EQ 100GM BASE/VIAL N65141 001 Nov 29, 2006 Nov NEWA
>A> + EQ 300GM BASE/VIAL N65141 002 Nov 29, 2006 Nov NEWA
CEFPROZIL
TABLET; ORAL
CEFPROZIL
>A> AB RANBAXY 250MG N65198 001 Dec 13, 2006 Nov NEWA
>A> AB 500MG N65198 002 Dec 13, 2006 Nov NEWA
CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX
SUSPENSION, EXTENDED RELEASE; ORAL
>D> TUSSIONEX
>D> + UCB INC EQ 8MG MALEATE/5ML;EQ 10MG N19111 001 Dec 31, 1987 Nov CTNA
>A> TUSSIONEX PENNKINETIC
>A> + UCB INC EQ 8MG MALEATE/5ML;EQ 10MG N19111 001 Dec 31, 1987 Nov CTNA
CIPROFLOXACIN
SOLUTION/DROPS; OPHTHALMIC
CIPROFLOXACIN
>A> AT NEXUS PHARMS EQ 0.3% BASE N77689 001 Dec 13, 2006 Nov NEWA
CITALOPRAM HYDROBROMIDE
TABLET; ORAL
CITALOPRAM HYDROBROMIDE
>A> AB INTERPHARM EQ 10MG BASE N77289 001 Nov 30, 2006 Nov NEWA
>A> AB EQ 20MG BASE N77289 002 Nov 30, 2006 Nov NEWA
>A> AB EQ 40MG BASE N77289 003 Nov 30, 2006 Nov NEWA
>A> CLINDAMYCIN PHOSPHATE; TRETINOIN
>A> GEL; TOPICAL
>A> ZIANA
>A> + MEDICIS 1.2%;0.025% N50802 001 Nov 07, 2006 Nov NEWA
CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
SYRUP; ORAL
>A> PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE
>A> AA VINTAGE 10MG/5ML;5MG/5ML;6.25MG/5ML N40660 001 Dec 07, 2006 Nov NEWA
PROMETH VC W/ CODEINE
>D> + ACTAVIS MID 10MG/5ML;5MG/5ML;6.25MG/5ML N88764 001 Oct 31, 1984 Nov CFTG
>A> AA + 10MG/5ML;5MG/5ML;6.25MG/5ML N88764 001 Oct 31, 1984 Nov CFTG
CYANOCOBALAMIN
INJECTABLE; INJECTION
CYANOCOBALAMIN
>D> AP ABRAXIS PHARM 0.1MG/ML N80557 002 Nov DISC
>A> @ 0.1MG/ML N80557 002 Nov DISC
>D> AP BIONICHE PHARMA 1MG/ML N40451 001 Sep 23, 2003 Nov CRLD
>A> AP + 1MG/ML N40451 001 Sep 23, 2003 Nov CRLD
>D> AP LUITPOLD 1MG/ML N80737 001 Nov CRLD
>A> AP + 1MG/ML N80737 001 Nov CRLD
>D> AP WATSON LABS 0.1MG/ML N80573 002 Nov DISC
>A> @ 0.1MG/ML N80573 002 Nov DISC
>D> AP 1MG/ML N80573 001 Nov DISC
>A> @ 1MG/ML N80573 001 Nov DISC
>D> RUBRAMIN PC
>D> AP + BRISTOL MYERS 1MG/ML N06799 010 Apr 28, 1988 Nov DISC
>A> @ 1MG/ML N06799 010 Apr 28, 1988 Nov DISC
VIBISONE
>D> AP ABRAXIS PHARM 1MG/ML N80557 003 Nov CRLD
>A> AP + 1MG/ML N80557 003 Nov CRLD
DOXYCYCLINE
TABLET; ORAL
DOXYCYCLINE
>A> AB SANDOZ EQ 50MG BASE N65353 001 Nov 27, 2006 Nov NEWA
>A> AB EQ 75MG BASE N65353 002 Nov 27, 2006 Nov NEWA
>A> AB EQ 100MG BASE N65353 003 Nov 27, 2006 Nov NEWA
FLUCONAZOLE
TABLET; ORAL
FLUCONAZOLE
>D> AB GEDEON RICHTER 50MG N76432 001 Jul 29, 2004 Nov DISC
>A> @ 50MG N76432 001 Jul 29, 2004 Nov DISC
>D> AB 100MG N76432 002 Jul 29, 2004 Nov DISC
>A> @ 100MG N76432 002 Jul 29, 2004 Nov DISC
>D> AB 150MG N76432 003 Jul 29, 2004 Nov DISC
>A> @ 150MG N76432 003 Jul 29, 2004 Nov DISC
>D> AB 200MG N76432 004 Jul 29, 2004 Nov DISC
>A> @ 200MG N76432 004 Jul 29, 2004 Nov DISC
GENTAMICIN SULFATE
INJECTABLE; INJECTION
GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>D> AP B BRAUN EQ 0.8MG BASE/ML N62814 001 Aug 28, 1987 Nov CRLD
>A> AP + EQ 0.8MG BASE/ML N62814 001 Aug 28, 1987 Nov CRLD
>D> AP EQ 1.2MG BASE/ML N62814 002 Aug 28, 1987 Nov CRLD
>A> AP + EQ 1.2MG BASE/ML N62814 002 Aug 28, 1987 Nov CRLD
>D> AP EQ 1.4MG BASE/ML N62814 003 Aug 28, 1987 Nov CRLD
>A> AP + EQ 1.4MG BASE/ML N62814 003 Aug 28, 1987 Nov CRLD
>D> AP EQ 1.6MG BASE/ML N62814 004 Aug 28, 1987 Nov CRLD
>A> AP + EQ 1.6MG BASE/ML N62814 004 Aug 28, 1987 Nov CRLD
>D> AP EQ 1.8MG BASE/ML N62814 005 Aug 28, 1987 Nov CRLD
>A> AP + EQ 1.8MG BASE/ML N62814 005 Aug 28, 1987 Nov CRLD
>D> AP EQ 2MG BASE/ML N62814 006 Aug 28, 1987 Nov CRLD
>A> AP + EQ 2MG BASE/ML N62814 006 Aug 28, 1987 Nov CRLD
>D> AP EQ 2.4MG BASE/ML N62814 007 Aug 28, 1987 Nov CRLD
>A> AP + EQ 2.4MG BASE/ML N62814 007 Aug 28, 1987 Nov CRLD
>D> AP EQ 40MG BASE/100ML N62814 008 Aug 28, 1987 Nov CRLD
>A> AP + EQ 40MG BASE/100ML N62814 008 Aug 28, 1987 Nov CRLD
>D> AP EQ 60MG BASE/100ML N62814 009 Aug 28, 1987 Nov CRLD
>A> AP + EQ 60MG BASE/100ML N62814 009 Aug 28, 1987 Nov CRLD
>D> AP EQ 70MG BASE/100ML N62814 010 Aug 28, 1987 Nov CRLD
>A> AP + EQ 70MG BASE/100ML N62814 010 Aug 28, 1987 Nov CRLD
>D> AP EQ 80MG BASE/100ML N62814 011 Aug 28, 1987 Nov CRLD
>A> AP + EQ 80MG BASE/100ML N62814 011 Aug 28, 1987 Nov CRLD
>D> AP EQ 90MG BASE/100ML N62814 012 Aug 28, 1987 Nov CRLD
>A> AP + EQ 90MG BASE/100ML N62814 012 Aug 28, 1987 Nov CRLD
>D> AP EQ 100MG BASE/100ML N62814 013 Aug 28, 1987 Nov CRLD
>A> AP + EQ 100MG BASE/100ML N62814 013 Aug 28, 1987 Nov CRLD
>D> AP EQ 120MG BASE/100ML N62814 014 Aug 28, 1987 Nov CRLD
>A> AP + EQ 120MG BASE/100ML N62814 014 Aug 28, 1987 Nov CRLD
HYDROCHLOROTHIAZIDE; TRIAMTERENE
TABLET; ORAL
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
>A> AB APOTEX INC 25MG;37.5MG N71251 002 May 05, 1998 Nov CAHN
>A> AB 50MG;75MG N71251 001 Apr 17, 1988 Nov CAHN
>D> AB BARR 25MG;37.5MG N71251 002 May 05, 1998 Nov CAHN
>D> AB 50MG;75MG N71251 001 Apr 17, 1988 Nov CAHN
IMATINIB MESYLATE
CAPSULE; ORAL
GLEEVEC
>D> @ NOVARTIS 50MG N21335 001 May 10, 2001 Nov CPOT
>A> @ EQ 50MG BASE N21335 001 May 10, 2001 Nov CPOT
>D> @ 100MG N21335 002 May 10, 2001 Nov CPOT
>A> @ EQ 100MG BASE N21335 002 May 10, 2001 Nov CPOT
TABLET; ORAL
GLEEVEC
>D> NOVARTIS 100MG N21588 001 Apr 18, 2003 Nov CPOT
>A> EQ 100MG BASE N21588 001 Apr 18, 2003 Nov CPOT
>D> + 400MG N21588 002 Apr 18, 2003 Nov CPOT
>A> + EQ 400MG BASE N21588 002 Apr 18, 2003 Nov CPOT
LEVOTHYROXINE SODIUM
TABLET; ORAL
LEVOTHYROXINE SODIUM
>A> AB1, MYLAN 0.137MG N76187 012 Dec 13, 2006 Nov NEWA
LEVOXYL
>D> AB3 JONES PHARMA 0.137MG N21301 008 May 25, 2001 Nov CTEC
>A> AB1, 0.137MG N21301 008 May 25, 2001 Nov CTEC
SYNTHROID
>D> AB2 ABBOTT 0.137MG N21402 008 Jul 24, 2002 Nov CTEC
>A> AB1, 0.137MG N21402 008 Jul 24, 2002 Nov CTEC
LORAZEPAM
TABLET; ORAL
LORAZEPAM
>A> AB IVAX PHARMS 0.5MG N77396 001 Dec 13, 2006 Nov NEWA
>A> AB 1MG N77396 002 Dec 13, 2006 Nov NEWA
>A> AB 2MG N77396 003 Dec 13, 2006 Nov NEWA
MELOXICAM
TABLET; ORAL
MELOXICAM
>A> AB CARLSBAD 7.5MG N77918 001 Dec 07, 2006 Nov NEWA
>A> AB 15MG N77918 002 Dec 07, 2006 Nov NEWA
>A> AB RANBAXY 7.5MG N78039 001 Dec 14, 2006 Nov NEWA
>A> AB 15MG N78039 002 Dec 14, 2006 Nov NEWA
METOPROLOL TARTRATE
TABLET; ORAL
METOPROLOL TARTRATE
>D> AB APOTHECON 50MG N74258 001 Jan 27, 1994 Nov DISC
>A> @ 50MG N74258 001 Jan 27, 1994 Nov DISC
>D> AB 100MG N74258 002 Jan 27, 1994 Nov DISC
>A> @ 100MG N74258 002 Jan 27, 1994 Nov DISC
MOEXIPRIL HYDROCHLORIDE
TABLET; ORAL
MOEXIPRIL HYDROCHLORIDE
>A> AB PADDOCK 7.5MG N77536 001 Nov 30, 2006 Nov NEWA
>A> AB 15MG N77536 002 Nov 30, 2006 Nov NEWA
NICOTINE
SPRAY, METERED; NASAL
NICOTROL
>A> + PFIZER INC 0.5MG/SPRAY N20385 001 Mar 22, 1996 Nov CAHN
>D> + PHARMACIA AND 0.5MG/SPRAY N20385 001 Mar 22, 1996 Nov CAHN
NIFEDIPINE
TABLET, EXTENDED RELEASE; ORAL
NIFEDIPINE
>A> AB1 ABRIKA PHARMS 30MG N77899 001 Dec 13, 2006 Nov NEWA
>A> AB1 60MG N77899 002 Dec 13, 2006 Nov NEWA
NITROGLYCERIN
>A> AEROSOL, METERED; SUBLINGUAL
>A> NITROMIST
>A> + NOVADEL 0.4MG/SPRAY N21780 001 Nov 02, 2006 Nov NEWA
NYSTATIN
POWDER; TOPICAL
NYSTATIN
>A> AT PHARMAFORCE 100,000 UNITS/GM N65203 001 Jul 15, 2004 Nov CAHN
>D> AT TANON 100,000 UNITS/GM N65203 001 Jul 15, 2004 Nov CAHN
ONDANSETRON
TABLET, ORALLY DISINTEGRATING; ORAL
ZOFRAN ODT
>D> GLAXOSMITHKLINE EQ 4MG BASE N20781 001 Jan 27, 1999 Nov CPOT
>A> 4MG N20781 001 Jan 27, 1999 Nov CPOT
>D> + EQ 8MG BASE N20781 002 Jan 27, 1999 Nov CPOT
>A> + 8MG N20781 002 Jan 27, 1999 Nov CPOT
ONDANSETRON HYDROCHLORIDE
INJECTABLE; INJECTION
>A> ONDANSETRON
>A> AP TEVA EQ 2MG BASE/ML N76876 001 Nov 22, 2006 Nov NEWA
>A> ONDANSETRON AND DEXTROSE IN PLASTIC CONTAINER
>A> AP SICOR PHARMS EQ 0.64MG BASE/ML N77480 001 Nov 22, 2006 Nov NEWA
>A> ONDANSETRON PRESERVATIVE FREE
>A> AP TEVA EQ 2MG BASE/ML N76759 001 Nov 22, 2006 Nov NEWA
ZOFRAN
>D> + GLAXOSMITHKLINE EQ 2MG BASE/ML N20007 001 Jan 04, 1991 Nov CFTG
>A> AP + EQ 2MG BASE/ML N20007 001 Jan 04, 1991 Nov CFTG
ZOFRAN IN PLASTIC CONTAINER
>D> + GLAXOSMITHKLINE EQ 0.64MG BASE/ML N20403 001 Jan 31, 1995 Nov CFTG
>A> AP + EQ 0.64MG BASE/ML N20403 001 Jan 31, 1995 Nov CFTG
ZOFRAN PRESERVATIVE FREE
>D> + GLAXOSMITHKLINE EQ 2MG BASE/ML N20007 003 Dec 10, 1993 Nov CFTG
>A> AP + EQ 2MG BASE/ML N20007 003 Dec 10, 1993 Nov CFTG
OXALIPLATIN
INJECTABLE; IV (INFUSION)
ELOXATIN
>A> + SANOFI AVENTIS US 200MG/40ML (5MG/ML) N21759 003 Nov 17, 2006 Nov NEWA
OXANDROLONE
TABLET; ORAL
OXANDRIN
>D> SAVIENT PHARMS 2.5MG N13718 001 Nov CFTG
>A> AB 2.5MG N13718 001 Nov CFTG
>D> + 10MG N13718 002 Nov 05, 2001 Nov CFTG
>A> AB + 10MG N13718 002 Nov 05, 2001 Nov CFTG
>A> OXANDROLONE
>A> AB SANDOZ 2.5MG N76897 001 Dec 01, 2006 Nov NEWA
>A> AB 10MG N76897 002 Dec 01, 2006 Nov NEWA
>A> AB UPSHER SMITH 2.5MG N76761 001 Dec 01, 2006 Nov NEWA
PACLITAXEL
INJECTABLE; INJECTION
PACLITAXEL
>D> AP BAKER NORTON 6MG/ML N75184 001 Jan 25, 2002 Nov CAHN
>A> AP DABUR ONCOLOGY 6MG/ML N77574 001 Nov 27, 2006 Nov NEWA
>D> AP IVAX PHARMS 6MG/ML N75297 001 Jan 25, 2002 Nov CAHN
>A> AP SICOR PHARMS 6MG/ML N75297 001 Jan 25, 2002 Nov CAHN
>A> AP 6MG/ML N75184 001 Jan 25, 2002 Nov CAHN
PAROXETINE HYDROCHLORIDE
SUSPENSION; ORAL
>A> PAROXETINE HYDROCHLORIDE
>A> AB APOTEX INC EQ 10MG BASE/5ML N77395 001 Dec 05, 2006 Nov NEWA
PAXIL
>D> + GLAXOSMITHKLINE EQ 10MG BASE/5ML N20710 001 Jun 25, 1997 Nov CFTG
>A> AB + EQ 10MG BASE/5ML N20710 001 Jun 25, 1997 Nov CFTG
PENICILLIN V POTASSIUM
TABLET; ORAL
>D> VEETIDS
>D> AB APOTHECON EQ 250MG BASE N61411 001 Nov DISC
>A> @ EQ 250MG BASE N61411 001 Nov DISC
>D> AB EQ 500MG BASE N61411 002 Nov DISC
>A> @ EQ 500MG BASE N61411 002 Nov DISC
PHENTERMINE HYDROCHLORIDE
CAPSULE; ORAL
PHENTERMINE HYDROCHLORIDE
>D> AA + SANDOZ 15MG N87301 001 Nov DISC
>A> @ 15MG N87301 001 Nov DISC
>A> AA + 15MG N87190 002 Nov CMS1
>D> AA 30MG N87223 001 Nov DISC
>A> @ 30MG N87223 001 Nov DISC
>D> AA 30MG N87208 001 Nov DISC
>A> @ 30MG N87208 001 Nov DISC
PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
SYRUP; ORAL
>A> PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE
>A> AA VINTAGE 5MG/5ML;6.25MG/5ML N40654 001 Dec 07, 2006 Nov NEWA
PROMETH VC PLAIN
>D> + ACTAVIS MID 5MG/5ML;6.25MG/5ML N88761 001 Nov 08, 1984 Nov CFTG
>A> AA + 5MG/5ML;6.25MG/5ML N88761 001 Nov 08, 1984 Nov CFTG
PHENYTOIN SODIUM
CAPSULE; ORAL
EXTENDED PHENYTOIN SODIUM
>A> AB SUN PHARM INDS (IN) 100MG EXTENDED N40621 001 Dec 11, 2006 Nov NEWA
PRAVASTATIN SODIUM
TABLET; ORAL
PRAVASTATIN SODIUM
>A> AB PLIVA HRVATSKA DOO 10MG N77730 001 Nov 21, 2006 Nov NEWA
>A> AB 20MG N77730 002 Nov 21, 2006 Nov NEWA
>A> 30MG N77730 003 Nov 21, 2006 Nov NEWA
>A> AB 40MG N77730 005 Nov 21, 2006 Nov NEWA
PROPYLTHIOURACIL
TABLET; ORAL
PROPYLTHIOURACIL
>D> BD IMPAX LABS 50MG N80159 001 Nov DISC
>A> @ 50MG N80159 001 Nov DISC
RIBAVIRIN
TABLET; ORAL
COPEGUS
>D> AB + ROCHE 200MG N21511 001 Dec 03, 2002 Nov CRLD
>A> AB 200MG N21511 001 Dec 03, 2002 Nov CRLD
>D> SAQUINAVIR
>D> CAPSULE; ORAL
>D> FORTOVASE
>D> + HLR 200MG N20828 001 Nov 07, 1997 Nov DISC
>A> @ 200MG N20828 001 Nov 07, 1997 Nov DISC
SOYBEAN OIL
INJECTABLE; INJECTION
>D> SOYACAL 10%
>D> AP + ALPHA THERA 10% N18465 001 Jun 29, 1983 Nov DISC
>A> @ 10% N18465 001 Jun 29, 1983 Nov DISC
>D> SOYACAL 20%
>D> AP + ALPHA THERA 20% N18786 001 Jun 29, 1983 Nov DISC
>A> @ 20% N18786 001 Jun 29, 1983 Nov DISC
SULFACETAMIDE SODIUM
LOTION; TOPICAL
KLARON
>D> + SANOFI AVENTIS US 10% N19931 001 Dec 23, 1996 Nov CFTG
>A> AB + 10% N19931 001 Dec 23, 1996 Nov CFTG
>A> SULFACETAMIDE SODIUM
>A> AB ALTANA 10% N77015 001 Nov 17, 2006 Nov NEWA
TAMOXIFEN CITRATE
SOLUTION; ORAL
SOLTAMOX
>A> + ROSEMONT EQ 10MG BASE/5ML N21807 001 Oct 29, 2005 Nov CAHN
>D> + SAVIENT PHARMS EQ 10MG BASE/5ML N21807 001 Oct 29, 2005 Nov CAHN
TESTOSTERONE CYPIONATE
INJECTABLE; INJECTION
TESTOSTERONE CYPIONATE
>A> AO SYNERX PHARMA 200MG/ML N40652 001 Dec 11, 2006 Nov NEWA
THEOPHYLLINE
TABLET, EXTENDED RELEASE; ORAL
UNIPHYL
>D> AB + PURDUE FREDERICK 400MG N87571 001 Sep 01, 1982 Nov CRLD
>A> AB 400MG N87571 001 Sep 01, 1982 Nov CRLD
TRANDOLAPRIL
TABLET; ORAL
MAVIK
>D> ABBOTT 1MG N20528 001 Apr 26, 1996 Nov CFTG
>A> AB 1MG N20528 001 Apr 26, 1996 Nov CFTG
>D> 2MG N20528 002 Apr 26, 1996 Nov CFTG
>A> AB 2MG N20528 002 Apr 26, 1996 Nov CFTG
>D> + 4MG N20528 003 Apr 26, 1996 Nov CFTG
>A> AB + 4MG N20528 003 Apr 26, 1996 Nov CFTG
>A> TRANDOLAPRIL
>A> AB TEVA PHARMS 1MG N77489 001 Dec 12, 2006 Nov NEWA
>A> AB 2MG N77489 002 Dec 12, 2006 Nov NEWA
>A> AB 4MG N77489 003 Dec 12, 2006 Nov NEWA
TRAZODONE HYDROCHLORIDE
TABLET; ORAL
TRAZODONE HYDROCHLORIDE
>A> AB APOTEX INC 100MG N71196 001 Mar 25, 1987 Nov CAHN
>A> AB 150MG N71196 002 Apr 26, 1999 Nov CAHN
>A> AB + 300MG N71196 003 Apr 26, 1999 Nov CAHN
>D> AB BARR 100MG N71196 001 Mar 25, 1987 Nov CAHN
>D> AB 150MG N71196 002 Apr 26, 1999 Nov CAHN
>D> AB + 300MG N71196 003 Apr 26, 1999 Nov CAHN
TRETINOIN
CREAM; TOPICAL
TRETINOIN
>D> AB SPEAR PHARMS 0.025% N75264 001 Dec 24, 1998 Nov CAHN
>D> AB1 0.05% N75265 001 Dec 24, 1998 Nov CAHN
>D> AB 0.1% N75213 001 Dec 24, 1998 Nov CAHN
>A> AB TRIAX PHARMS LLC 0.025% N75264 001 Dec 24, 1998 Nov CAHN
>A> AB1 0.05% N75265 001 Dec 24, 1998 Nov CAHN
>A> AB 0.1% N75213 001 Dec 24, 1998 Nov CAHN
TRIAMCINOLONE ACETONIDE
LOTION; TOPICAL
TRIAMCINOLONE ACETONIDE
>A> AT VINTAGE 0.1% N40672 002 Dec 13, 2006 Nov NEWA
SPRAY, METERED; NASAL
>D> NASACORT HFA
>D> + SANOFI AVENTIS US 0.055MG/SPRAY N20784 001 Apr 07, 2004 Nov DISC
>A> @ 0.055MG/SPRAY N20784 001 Apr 07, 2004 Nov DISC
VERAPAMIL HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
ISOPTIN SR
>A> AB + FSC 120MG N19152 003 Mar 06, 1991 Nov CAHN
>A> AB + 180MG N19152 002 Dec 15, 1989 Nov CAHN
>A> AB + 240MG N19152 001 Dec 16, 1986 Nov CAHN
>D> AB + PAR PHARM 120MG N19152 003 Mar 06, 1991 Nov CAHN
>D> AB + 180MG N19152 002 Dec 15, 1989 Nov CAHN
>D> AB + 240MG N19152 001 Dec 16, 1986 Nov CAHN
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL
SPONGE; TOPICAL
CHLORAPREP ONE-STEP
>A> + MEDI FLEX INC 2%;70% (26ML) N20832 006 Nov 21, 2006 Nov NEWA
INSULIN RECOMBINANT HUMAN
INJECTABLE; INJECTION
>D> VELOSULIN BR
>D> + NOVO NORDISK INC 100 UNITS/ML N21028 001 Jul 19, 1999 Nov DISC
>A> @ 100 UNITS/ML N21028 001 Jul 19, 1999 Nov DISC
INSULIN ZINC SUSP RECOMBINANT HUMAN
INJECTABLE; INJECTION
>D> NOVOLIN L
>D> NOVO NORDISK INC 100 UNITS/ML N19965 001 Jun 25, 1991 Nov DISC
>A> @ 100 UNITS/ML N19965 001 Jun 25, 1991 Nov DISC
POLYETHYLENE GLYCOL 3350
FOR SOLUTION; ORAL
MIRALAX
>D> + BRAINTREE 17GM/SCOOPFUL N22015 001 Oct 06, 2006 Nov CAHN
>A> + SCHERING PLOUGH 17GM/SCOOPFUL N22015 001 Oct 06, 2006 Nov CAHN
Date created: December 14, 2006 |
![](https://webarchive.library.unt.edu/eot2008/20090118123705im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |